Dilation of Malignant Strictures in Endoscopic Ultrasound Staging of Esophageal Cancer and Metastatic Spread of Disease

Table 2

Location of metastases by time from staging EUS in patients who did and did not undergo dilation at the time of staging EUS.

	Dilated group	Nondilated group
Location of metastases detected at <6 months (total number of occurrences)	4 patients Mediastinal lymph nodes (2) Lungs (1) Pleural effusion (1) Axillary lymph nodes (1) Adrenal gland (1) Gastric lymph nodes (1)	4 patients Liver (2) Peritoneum (2) Back (1)
Location of metastases detected at 6–12 months (total number of occurrences)	2 patients Recurrence at GE junction (2) Diffuse bony metastases (1) Mediastinal lymph nodes (1)	5 patients Liver (3) Lungs (2) Pleural effusion (2) Peritoneum (1) Recurrence at GE junction (1)
Location of metastases detected at >12 months (total number of occurrences)	4 patients Recurrence at GE junction (1) Axillary lymph nodes (1) Cervical lymph nodes (1) Neck (1) Mediastinum (1)	3 patients Recurrence at GE junction (1) Lungs (1) Abdominal mass (1)
Median time to detection of metastases (range)	10 months (1–54 months)	10 months (1–125 months)